Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 Advancements in chemotherapy treatments
3.2.1.3 Growing focus on personalized medicine
3.2.1.4 Growth in government funding for cancer research
3.2.2 Industry pitfalls & challenges
3.2.2.1 Availability of alternative therapies
3.2.2.2 Side effects associated with the medication
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Regulatory landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Formulation, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Lyophilized powder
5.3 Doxorubicin injection
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Breast cancer
6.3 Liver cancer
6.4 Kidney cancer
6.5 Sarcoma
6.6 Ovarian cancer
6.7 Lung cancer
6.8 Leukemia
6.9 Multiple myeloma
6.10 Other types of cancer
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacy
7.3 Retail pharmacy
7.4 Online pharmacy
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Accord Healthcare
9.2 Baxter International Inc.
9.3 Cipla Ltd.
9.4 Dr. Reddy's Laboratories Limited
9.5 Fresenius SE & Co. KGaA
9.6 Johnson and Johnson
9.7 Hikma Pharmaceuticals PLC
9.8 Lupin Limited
9.9 Meiji Holdings Co. Ltd.
9.10 Novartis AG
9.11 Pfizer Inc.
9.12 Sun Pharmaceutical Industries Ltd.
9.13 Sanofi
9.14 Teva Pharmaceutical Industries Ltd.
9.15 Viatris Inc.
9.16 Zydus Lifesciences Limited
